1.Identify scenarios in which bridging anticoagulation may be appropriate.
2. Identify scenarios in which bridging anticoagulation may be inappropriate.
3.Explain when non-inferiority studies may be useful, and list methodologic considerations when assessing the rigor of a non-inferiority study.
1.Understand that when considering bridging anticoagulation, necessarily assess both risk of thromboembolic event and patient/procedural risks for bleeding.
2. Understand potential options for restricting bridging to those at highest risk
3. Compare and contrast evidence for bridging in atrial fibrillation compared to venous thromboembolic disease
11/28/2016 - 12:00pm to 1:00pm CST
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Shannon Martin, MD, MS & Joyce Tang MD. MPH